Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Design Therapeutics, Inc. | Director | Common Stock | 1.3K | $4.87K | $3.74 | Mar 25, 2024 | Direct |
Design Therapeutics, Inc. | Director | Stock Option (right to buy) | 19K | Jun 13, 2024 | Direct | ||
Entasis Therapeutics Holdings Inc. | Director | Common Stock | 0 | $2.20 | Jul 11, 2022 | Direct | |
Entasis Therapeutics Holdings Inc. | Director | Stock Option (right to buy) | 0 | Jul 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DSGN | Design Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
DSGN | Design Therapeutics, Inc. | Mar 25, 2024 | 1 | $4.87K | 4 | Mar 25, 2024 | Director |
DSGN | Design Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
ETTX | Entasis Therapeutics Holdings Inc. | Jul 7, 2022 | 4 | -$109K | 4 | Jul 11, 2022 | Director |
DSGN | Design Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
ETTX | Entasis Therapeutics Holdings Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Director |
ETTX | Entasis Therapeutics Holdings Inc. | Jul 16, 2021 | 4 | $0 | 4 | Feb 15, 2022 | Director |
DSGN | Design Therapeutics, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |
DSGN | Design Therapeutics, Inc. | Jun 15, 2021 | 0 | $0 | 3 | Jun 16, 2021 | Director |